Amazon upgraded, Adobe downgraded: Wall Street's top analyst calls

Micron is experiencing robust AI-driven demand for its products and is expected to deliver strong growth in fiscal 2026.

UDR has underperformed the real estate sector over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

Check out the companies making headlines yesterday:

The government’s stake in Intel has increased by 50% after Nvidia invested in the company.

Micron shares were little changed in premarket trading Wednesday after the memory chip maker posted better-than-expected quarterly results and issued a rosy forecast amid surging AI-related demand. Monitor these important chart levels.

This could be the next multibagger hiding in biotech under $10.

MGM Resorts is underperforming the Dow Jones over the past year, but analysts remain moderately bullish about the stock’s prospects.

As Wynn Resorts has considerably outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.

Bio-Techne has significantly underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Ralph Lauren has surpassed its industry peers over the past year, with analysts maintaining a cautiously optimistic outlook on the stock’s future potential.

A. O. Smith has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Jack Henry & Associates has trailed the broader tech sector in the past year, prompting analysts to take a more guarded stance on the stock’s outlook.

Insulet has outperformed the S&P 500 over the past year, and analysts are highly optimistic about the stock’s prospects.

Over the past year, Universal Health Services has lagged its industry peers, yet analysts continue to maintain a fairly positive outlook on the stock’s potential.